drugset / Trial / NCT00395603

Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)

NCT00395603

Phase 3 Terminated 550 enrolled Organon and Co
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the effectiveness of ezetimibe/simvastatin 10/40 daily to atorvastatin 80 daily in reducing the concentration of ldl-c at endpoint after 6 weeks of treatment.

Timeline

Start
2006-09
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg
Subject Ezetimibe Unknown 10 mg
Subject Simvastatin Small molecule 40 mg